OPK #1 Covid-19 Testing Play

NIA is excited to announce OPKO Health (OPK) here at $2.08 per share as its #1 Covid-19 testing stock suggestion. OPK is the owner of BioReference Laboratories one of the largest full-service clinical diagnostics laboratories in the U.S.

OPK has 98 million shares sold short and we believe it will rise to $3 per share in the upcoming weeks.

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. This message is meant for informational and educational purposes only and does not provide investment advice.